These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4097361)

  • 1. [Treatment of prostatic hypertrophy with 19-norhydroxyprogesterone caproate].
    Kato T; Okada K
    Hinyokika Kiyo; 1970 Sep; 16(9):489-500. PubMed ID: 4097361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prostatic hypertrophy with progestational steroid (gestonorone caproate)].
    Tanaka H; Fukushige M; Shiraishi T
    Hinyokika Kiyo; 1970 Sep; 16(9):531-50. PubMed ID: 4097365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of SH 582 (gestonorone caproate) for prostatic hypertrophy].
    Ochiai K; Komase M; Oshima H; Negishi T; Yamauchi A
    Hinyokika Kiyo; 1970 Sep; 16(9):473-81. PubMed ID: 4097359
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical effects of SH 582 (gestonorone caproate) on benign prostatic hypertrophy].
    Momose S; Hidaka M; Oota Y; Oomaru K
    Hinyokika Kiyo; 1970 Sep; 16(9):551-4. PubMed ID: 4097366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progestogen therapy for prostatic hypertrophy].
    Tabayashi Y; Kawabata T; Sasaki H
    Hinyokika Kiyo; 1970 Sep; 16(9):459-72. PubMed ID: 4097964
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of gestonorone caproate on prostate and seminal vesicles of the rat].
    Hahn JD
    Hinyokika Kiyo; 1970 Sep; 16(9):429-37. PubMed ID: 5528737
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of 17-alpha-norhydroxy-progesterone caproate (SH 582) in treatment of prostatic hypertrophy].
    Hara S; Suemitsu H; Matsuda G; Fukuhara I; Shiba T
    Hinyokika Kiyo; 1970 Sep; 16(9):501-7. PubMed ID: 4097362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with SH-582 for prostatic hypertrophy with special reference to its effects on the thyroid function].
    Kuroda K; Nakamura T; Wada I
    Hinyokika Kiyo; 1970 Sep; 16(9):482-8. PubMed ID: 4097360
    [No Abstract]   [Full Text] [Related]  

  • 9. [Conservative treatment of benign prostatic hypertrophy with gestagen therapy by gestonorone caproate].
    Niijima T; Tanaka H; Takata M
    Hinyokika Kiyo; 1970 Sep; 16(9):508-22. PubMed ID: 4097363
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of 17-alpha-hydroxy-19-norprogesterone acaproate (SH-582) on prostatic hypertrophy with special reference to estimation of size of the prostate by means of ultrasonotomography].
    Watanabe H; Kaiho H; Takahashi H; Kato T; Shima M
    Hinyokika Kiyo; 1970 Sep; 16(9):438-45. PubMed ID: 4097357
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with SH 582 for prostatic hypertrophy].
    Kobayashi C; Miki M
    Hinyokika Kiyo; 1970 Sep; 16(9):446-9. PubMed ID: 4097358
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progestogen therapy of benign prostatic hypertrophy].
    Nakayama K; Okamoto K
    Hinyokika Kiyo; 1970 Sep; 16(9):558-60. PubMed ID: 4097367
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate].
    Nagel R; Hargenda B
    Hinyokika Kiyo; 1970 Sep; 16(9):423-8. PubMed ID: 4097356
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the effect of 19-nor-17alpha-hydroxyprogesterone caproate on the prostate, seminal vesicles and testis of the rat].
    Hahn JD; Neumann F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):131. PubMed ID: 4239169
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fundamental experiment on the influence of progestogen on the gonad of male albino rat].
    Nakayama K; Okamoto K
    Hinyokika Kiyo; 1970 Sep; 16(9):555-7. PubMed ID: 5528739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with SH 582 for prostatic hypertrophy; comparison with estrogen therapy].
    Terao N; Ogawa I; Fujimura N; Kondo K; Tsumagari I
    Hinyokika Kiyo; 1970 Sep; 16(9):523-30. PubMed ID: 4097364
    [No Abstract]   [Full Text] [Related]  

  • 17. Histological findings of the testis and prostate in rats after intramuscular administration of a progestogen (SH 582).
    Suzuki S; Ooi T; Tsuchiya A
    Hinyokika Kiyo; 1970 Sep; 16(9):450-8. PubMed ID: 5528738
    [No Abstract]   [Full Text] [Related]  

  • 18. Gestronol hexanoate (SH582) and benign prostatic hypertrophy.
    Pitchford AG
    Proc R Soc Med; 1972 Feb; 65(2):128-9. PubMed ID: 4117436
    [No Abstract]   [Full Text] [Related]  

  • 19. Dicofol formulation induced toxicity on testes and accessory reproductive organs in albino rats.
    Jadaramkunti UC; Kaliwal BB
    Bull Environ Contam Toxicol; 2002 Nov; 69(5):741-8. PubMed ID: 12375125
    [No Abstract]   [Full Text] [Related]  

  • 20. [On a new synthetic gestagen, gestonorone. Its use in the treatment of prostatic hypertrophy and histological control of its effects on the male gonad].
    Luciani L; Frizzi V
    Minerva Urol; 1969; 21(6):203-13. PubMed ID: 4104300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.